Cyclodepsipeptid | 19893-23-3

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 肽模拟物
• 英文名称: Cyclodepsipeptid
• 英文别名: Cyclohexadepsipeptid；Enniatin A；(3S)-3r,9c,15c-triisobutyl-6t,12t,18t-triisopropyl-4,10,16-trimethyl-1,7,13-trioxa-4,10,16-triaza-cyclooctadecane-2,5,8,11,14,17-hexaone；cyclo-(D-2-hydroxy-3-methyl-butyryl->N-methyl-L-leucyl->D-2-hydroxy-3-methyl-butyryl->N-methyl-L-leucyl->D-2-hydroxy-3-methyl-butyryl->N-methyl-L-leucyl)；4,10,16-Trimethyl-3,9,15-tris(2-methylpropyl)-6,12,18-tri(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone
• CAS: 19893-23-3
• 化学式: C₃₆H₆₃N₃O₉
• 分子量: 681.911
• InChiKey: WICJNWLMJRLFKQ-UHFFFAOYSA-N

物化性质

• 熔点：
  159-160 °C
• 沸点：
  848.0±65.0 °C(Predicted)
• 密度：
  1.012±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  7.6
• 重原子数：
  48
• 可旋转键数：
  9
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.83
• 拓扑面积：
  140
• 氢给体数：
  0
• 氢受体数：
  9

安全信息

• 危险等级：
  6.1(a)
• 包装等级：
  I
• 危险类别：
  6.1(a)
• 危险品运输编号：
  UN 2811

文献信息

• PF1022 DERIVATIVE, CYCLIC DEPSIPEPTIDE
  申请人：MEIJI SEIKA KAISHA LTD.

  公开号：EP0685469A1

  公开（公告）日：1995-12-06

  A novel PF1022 derivative as a cyclic depsipeptide, represented by general formula (I), or a salt thereof, having the vermifugal activity against various parasites living in man, domestic and pet animals, and the like and thus being useful as a vermicide for preventing or treating infectious diseases caused by parasites. In formula (I) R¹, R², R³ and R⁴ represent each independently alkyl, cyclohexylmethyl, optionally substituted benzyl, etc; and X, Y, Z and Q represent each independently methyl or hydrogen, excluding the case where all of the R¹, R³, X, Y, Z and Q represent methyl groups and R² and R⁴ represent benzyl groups at the same time.

  一种由通式(I)表示的新型 PF1022 衍生物，作为一种环状去肽或其盐，对寄生在人、家畜和宠物等体内的各种寄生虫具有驱虫活性，因此可用作预防或治疗由寄生虫引起的传染性疾病的杀虫剂。在式(I)中，R¹、R²、R³和R⁴各自独立地代表烷基、环己基甲基、任选取代的苄基等；X、Y、Z和Q各自独立地代表甲基或氢，不包括所有R¹、R³、X、Y、Z和Q均代表甲基且R²和R⁴同时代表苄基的情况。
• ABC TRANSPORTER INHIBITOR
  申请人：SUNTORY LIMITED

  公开号：EP1721901A1

  公开（公告）日：2006-11-15

  It is an object of the present invention to provide an ABC transporter inhibitor whereby the multi-drug resistance against anticancer drugs caused by amplification and expression of MDR1 gene, which is the most serious problem in chemotherapy for cancer, or the resistance against antifungal agents in mycotic diseases can be overcome. The present invention relates to an ABC transporter inhibitor containing enniatin or its analog as the active ingredient. The ABC transporter inhibitor of the present invention, being capable of inhibiting transport/excretion of a drug, especially an anticancer drug or an antifungal agent, from inside to outside of cells, is useful in preventing, suppressing, or inhibiting acquisition of resistance against various drugs.

  本发明的目的是提供一种 ABC 转运体抑制剂，从而克服因 MDR1 基因的扩增和表达而引起的对抗癌药物的多重耐药性（这是癌症化疗中最严重的问题）或霉菌病中对抗真菌药物的耐药性。本发明涉及一种以烯啶或其类似物为活性成分的 ABC 转运体抑制剂。本发明的ABC转运体抑制剂能够抑制药物，特别是抗癌药物或抗真菌药物从细胞内向细胞外的转运/排泄，因此可用于预防、抑制或抑制获得对各种药物的抗药性。
• Process for producing chimeric cyclooligodepsipeptides in filamentous fungi
  申请人：TECHNISCHE UNIVERSITAET BERLIN

  公开号：US10738316B2

  公开（公告）日：2020-08-11

  A method for obtaining at least one microbial secondary metabolite or a derivative thereof, the method includes the step of heterologous expression of at least one synthetase of the secondary metabolite in at least one filamentous fungus. Also disclosed is an expression cassette, a plasmid vector including the expression cassette, an expression host, cyclodepsipeptides and a chimeric cyclodepsipeptide synthetase.

  一种获得至少一种微生物次级代谢产物或其衍生物的方法，该方法包括在至少一种丝状真菌中异源表达次级代谢产物的至少一种合成酶的步骤。还公开了一种表达盒、包括表达盒的质粒载体、表达宿主、环肽和嵌合环肽合成酶。
• NOVEL 24-MEMBERED CYCLOOCTADEPSIPEPTIDES FROM FUNGAL STRAINS AND THEIR USE AS ANTHELMINTICS OR ENDOPARASITICIDES
  申请人：Bayer Intellectual Property GmbH

  公开号：EP2509967A1

  公开（公告）日：2012-10-17
• SAFENER COMPOSITIONS AND METHODS FOR REDUCING MYCOTOXINS
  申请人：Syngenta Participations AG

  公开号：EP2592931A1

  公开（公告）日：2013-05-22